
Iran Pharma , jointly organized by the Iranian Pharmaceutical Association and the Iranian Food and Drug Administration (FDA), successfully concluded from September 24 to 26, 2025 !

As an enterprise with solid strength deeply engaged in the field of drug delivery, Wanhai Medical participated in the exhibition with its meticulously crafted pen injectors. Its innovative technology and high-quality solutions left a deep impression on global exhibitors and industry visitors, making it one of the notable Chinese brand representatives at the event.


At the exhibition site, Wanhai Medical's pen injectors, with their groundbreaking innovative design and excellent quality, attracted numerous overseas clients to inquire in detail about core issues such as technical parameters, production capacity supply, and regional adaptation solutions.


This "face-to-face" in-depth interaction not only allowed Wanhai Medical to accurately grasp the demand differences of clients from various regions but also highlighted its first-mover advantage in the quality-first track.
During this Iran Pharma visit, the continuous stream of visitors at the booth successfully left a deep impression on attendees, thanks to the innovativeness of Wanhai Medical's pen injectors and its brand ethos of "Ingenuity and Intelligent Manufacturing."
Wanhai Medical's multiple pen injectors, having undergone iterative upgrades, attracted significant interest from numerous pharmaceutical companies due to their core advantages: "precise dose control, ergonomic design, safety and convenience, and independent patents ensuring no infringement risk."

As a leading Chinese pen injectors manufacturer, Wanhai Medical's current product portfolio includes disposable pen injectors, reusable pen injectors, and the latest products: PFS disposable pen injectors and disposable multi-dose pen injectors.

In the future, through more international exhibitions and exchange platforms, Wanhai Medical aims to deepen cooperation with global pharmaceutical industry partners, closely follow market demands, continuously innovate and develop, striving to reduce patient suffering and contribute to the growth of biopharmaceuticals !